Capasso Planning Partners’s Eli Lilly LLY Stock Holding History

Capasso Planning Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$631K	Hold	526	–	–	0.31%	43
2026 Q1	$484K	Hold	526	–	–	0.26%	47
2025 Q4	$565K	Sell	526 -284	-35%	-$272K	0.31%	40
2025 Q3	$618K	Sell	810 -619	-43%	-$461K	0.38%	39
2025 Q2	$1.11M	Sell	1,429 -417	-23%	-$324K	0.63%	26
2025 Q1	$1.53M	Sell	1,846 -184	-9%	-$153K	0.64%	33
2024 Q4	$1.57M	Sell	2,030 -1,001	-33%	-$829K	0.63%	32
2024 Q3	$2.69M	Sell	3,031 -196	-6%	-$176K	0.79%	23
2024 Q2	$2.92M	Buy	3,227 +2,818	+689%	+$2.25M	0.95%	24
2024 Q1	$318K	Sell	409 -8	-2%	-$5.69K	0.13%	84
2023 Q4	$243K	Buy	417 +3	+0.7%	+$1.75K	0.11%	91
2023 Q3	$222K	Buy	+414	New	+$213K	0.12%	88

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capasso Planning Partners's LLY Position: Q2 2026 in Review

Capasso Planning Partners held its Eli Lilly (LLY) position steady in Q2 2026 at 526 shares worth $631K. The position accounts for 0.31% of the portfolio, ranked #43.

Capasso Planning Partners first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.92M in Q2 2024. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Capasso Planning Partners held 526 shares of Eli Lilly worth $631K as of Q2 2026.
Capasso Planning Partners left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 0.31% of Capasso Planning Partners's portfolio in Q2 2026, its #43 holding.
Capasso Planning Partners first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
Capasso Planning Partners's Eli Lilly position peaked at $2.92M in Q2 2024.
4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Capasso Planning Partners's 13F filing for Q2 2026, filed 18 Aug 2026.